margin to the Fund on a timely basis may cause the Fund to delay redemption settlement dates or restrict, postpone, or limit the right of redemption.
Futures contracts are subject to liquidity risk. An FCM may impose risk limits on the Fund, which restrict the amount of exposure to futures
contracts that the Fund can obtain through the FCM. If the risk limits imposed by an FCM do not provide sufficient exposure, the Fund may not be able to achieve its investment objective.
Furthermore, effective immediately, the following disclosure is added after the first full paragraph in the risk factor titled There May Be
Circumstances That Could Prevent the Fund from Being Operated in a Manner Consistent with its Investment Objective on page 25 of the section of the Prospectus titled Risk FactorsOther Risks.
Additionally, natural or environmental disasters, such as earthquakes, fires, floods, hurricanes, tsunamis and other severe weather-related
phenomena generally, and widespread disease, including pandemics and epidemics, have been and may be highly disruptive to economies and markets, adversely impacting individual companies, sectors, industries, markets, currencies, interest and
inflation rates, credit ratings, investor sentiment, and other factors affecting the value of the Funds investments. Given the increasing interdependence among global economies and markets, conditions in one country, market, or region are
increasingly likely to adversely affect markets, issuers, and/or foreign exchange rates in other countries, including the U.S. Any such events could have a significant adverse impact on the value of the Funds investments and could result in
increased premiums or discounts to the Funds NAV. Additionally, the Fund rebalances its portfolio in accordance with the Index, and, therefore, any changes to the Indexs rebalance schedule will result in corresponding changes to the
Funds rebalance schedule.
The Shares trade on the NYSE Arca under the symbol UDN.
Investing in the Shares involves significant risks. See RISK FACTORS starting on page 13 of the Prospectus.
These securities have not been approved or disapproved by the Securities and Exchange Commission or any state securities commission nor has the Securities
and Exchange Commission passed upon the adequacy or accuracy of the Prospectus or this Prospectus Supplement No. 1. Any representation to the contrary is a criminal offense.
The Fund is not a mutual fund or any other type of investment company within the meaning of the Investment Company Act of 1940, as amended, and is not
subject to regulation thereunder.
THE COMMODITY FUTURES TRADING COMMISSION HAS NOT PASSED UPON THE MERITS OF PARTICIPATING IN THIS POOL NOR HAS
THE COMMISSION PASSED ON THE ADEQUACY OR ACCURACY OF THIS DISCLOSURE DOCUMENT.
The date of this Prospectus Supplement No. 1 is
April 7, 2020.
PLEASE RETAIN THIS SUPPLEMENT FOR FUTURE REFERENCE
P-DBUDN-PRO-1-SUP-1 040720